BioImage-2 Starts: Ultrasound Imaging for Cardiac Risk Prediction Looks at Disease Progression
Mount Sinai Heart and BioImage-2 LLC, today announced start of the BioImage-2 study. The BioImage-2 study investigates the progression of vascular atherosclerotic plaque in patients who previously participated in the BioImage study. That landmark study recruited 7,687...
